menu-search
LEXISNEXIS_ICON4_SIGNINSign-in LEXISNEXIS_ICONS_SUPPORTHelp

Research and development

View Life Sciences by content type:

News
Practice notes
Precedents
Q&As

Latest Life Sciences News

UK accession to Lugano Convention—is the door now closed?

UK accession to Lugano Convention—is the door now closed?

The following Arbitration news provides comprehensive and up to date legal information on UK accession to Lugano Convention—is the door now closed?

EU deepens probe of Illumina’s $US8bn cancer detection deal

EU deepens probe of Illumina’s $US8bn cancer detection deal

The following EU Law news provides comprehensive and up to date legal information on EU deepens probe of Illumina’s $US8bn cancer detection deal

TCC grants AA 1996, s 9 stay applying the presumption in favour of ‘one stop adjudication’ in multi-contract scenario (Surrey County Council v Suez Recycling and Recovery Surrey)

TCC grants AA 1996, s 9 stay applying the presumption in favour of ‘one stop adjudication’ in multi-contract scenario (Surrey County Council v Suez Recycling and Recovery Surrey)

TCC grants AA 1996, s 9 stay applying the presumption in favour of ‘one stop adjudication’ in multi-contract scenario (Surrey County Council v Suez Recycling and Recovery Surrey)

Life Sciences weekly highlights—22 July 2021

Life Sciences weekly highlights—22 July 2021

The following Life Sciences news provides comprehensive and up to date legal information on Life Sciences weekly highlights—22 July 2021

Featured Life Sciences content

Joint, several, and joint and several liability

Joint, several, and joint and several liability

Joint, several, and joint and several liabilityContractWhere a contract is made by two or more parties it may contain a promise or obligation made by...

Conditions precedent in commercial contracts

Conditions precedent in commercial contracts

Conditions precedent in commercial contractsThis Practice Note considers the meaning and use of conditions precedent in commercial arrangements. It...

Sub-licensing intellectual property rights

Sub-licensing intellectual property rights

An intellectual property (IP) owner may choose to license its IP to a third party. This can be an effective route to generating revenue while...

Co-operative and community benefit societies

Co-operative and community benefit societies

Co-operative and community benefit societiesWhat is a co-operative or community benefit society?A co-operative society or community benefit society...

Practice notes

Rome II—application and interpretation

Rome II—application and interpretationThis Practice Note is for use when determining applicable law in respect of events giving rise to damage, where...
Read More >
19th May
Q&As

Can a third party rely on ostensible/apparent authority where they know the person signing a document is an employee of a company not a director and they sign as a director and in the name of that director?

Can a third party rely on ostensible/apparent authority where they know the person signing a document is an employee of a company not a director and...
Read More >
19th May
Practice notes

Brexit—exiting the EU under Article 50 [Archived]

Brexit—exiting the EU under Article 50 [Archived]ARCHIVED: This Practice Note has been archived and is not maintained.This Practice Note contains...
Read More >
Produced in partnership with Adam Cygan of University of Leicester 19th May
tag iconBrexit
Practice notes

Antibiotic drug Nitrofurantoin (AMCo, Morningside Healthcare, Morningside Pharmaceuticals and Alliance Healthcare) (50507)

Antibiotic drug Nitrofurantoin (AMCo, Morningside Healthcare, Morningside Pharmaceuticals and Alliance Healthcare) (50507)CASE HUB See further,...
Read More >
19th May
Q&As

Can the board of a co-operative and community benefit society (a registered society) delegate powers to any third party, and can the registered society grant a power of attorney to a third party to execute documents on its behalf?

Can the board of a co-operative and community benefit society (a registered society) delegate powers to any third party, and can the registered...
Read More >
19th May
Practice notes

Rome Convention—introduction and interpretation [Archived]

Rome Convention—introduction and interpretation [Archived]ARCHIVED: This Practice Note has been archived and is not maintained.The UK is no longer...
Read More >
19th May
Precedents

Force majeure clause

Coronavirus (COVID-19): In addition to the below content on force majeure generally, see also: • Coronavirus (COVID-19)...
Read More >
19th May
tag iconCOVID-19 tag iconIn-house
Practice notes

Managing a breach of confidentiality or information security

Many companies and government bodies (such as HMRC) have been exposed to loss of confidential information and many other breaches of confidentiality...
Read More >
19th May
Practice notes

Introduction to retained EU law

Introduction to retained EU lawThis Practice Note provides an introduction to retained EU law. It provides an overview of the key definitions and...
Read More >
Produced in partnership with Dr. Kieran Laird of Gowling WLG 19th May
tag iconBrexit
Precedents

Counterparts clause

1 Counterparts—agreement 1.1 This agreement may be signed in any number of separate counterparts, each of which when...
Read More >
19th May
tag iconIn-house
Practice notes

Model ADR clauses

Model ADR clausesThis Practice Note considers model form alternative dispute resolution (ADR) clauses provided by a number of service providers,...
Read More >
19th May
Precedents

Execution clause—company—contract

Option 1—contract signed on behalf of a company, where the authorised signatory is an individual Signed by [insert name of...
Read More >
19th May
tag iconIn-house
Practice notes

Requirements of the company seal

Requirements of the company sealThis Practice Note provides practical guidance regarding the requirements of the company seal. Where a company has a...
Read More >
19th May
Practice notes

Brexit implementation period—enforcement [Archived]

Brexit implementation period—enforcement [Archived]ARCHIVED: This Practice Note has been archived and is not maintained.This Practice Note considers...
Read More >
19th May
tag iconBrexit
Practice notes

Subcontracting

SubcontractingThis Practice Note examines the following legal and practical matters in relation to entering into a subcontract or when granting...
Read More >
19th May
Practice notes

Parallel imports

ScopeThis Practice Note explains trade mark law on parallel trade. Parallel imports, or ‘grey market’ goods, are genuine goods that are placed on the...
Read More >
Produced in partnership with Taylor Wessing LLP 19th May

Most recent Research and development content

Precedents

Confidentiality agreement—mutual

Confidentiality agreement—mutualThis Agreement is made on [date]Parties1[insert name of party] [of [insert details ] OR a company incorporated in...
Read More >
26th Jul
tag iconIn-house
Precedents

Clinical Research Organisation (CRO) master services agreement

Clinical Research Organisation (CRO) master services agreementIP COMPLETION DAY: 11pm (GMT) on 31 December 2020 marks the end of the Brexit...
Read More >
25th Jul
Precedents

Collaboration agreement

Collaboration agreementIP COMPLETION DAY: 11pm (GMT) on 31 December 2020 marks the end of the Brexit transition/implementation period entered into...
Read More >
25th Jul
tag iconIn-house
Practice notes

Know-how—protection and licensing

Know-how—protection and licensingThis Practice Note explains what know-how is and sets out the different ways know-how can be protected before...
Read More >
25th Jul
Practice notes

What does IP completion day mean for clinical trials?

What does IP completion day mean for clinical trials?11 pm (GMT) on 31 December 2020 marked the end of the implementation period put in place to...
Read More >
25th Jul
Precedents

Confidentiality agreement—one-way—pro-recipient

Confidentiality agreement—one-way—pro-recipientThis Agreement is made on [date]Parties1[Insert name of party] [of [insert address] OR a company...
Read More >
25th Jul
tag iconIn-house
Precedents

Confidentiality letter—mutual

Confidentiality letter—mutual[insert address of sender]Our ref: [insert reference]Your ref: [insert reference][Insert address of recipient]Date:...
Read More >
25th Jul
tag iconIn-house
Precedents

Research and development agreement (long form)

Research and development agreement (long form)IP COMPLETION DAY: 11pm (GMT) on 31 December 2020 marks the end of the Brexit transition/implementation...
Read More >
25th Jul
Precedents

Material transfer agreement

Material transfer agreementIP COMPLETION DAY: 11pm (GMT) on 31 December 2020 marks the end of the Brexit transition/implementation period entered into...
Read More >
Produced in partnership with Patricia Barclay of Bonaccord 25th Jul
Practice notes

Access to documents and information on medicinal products in the EU

Access to documents and information on medicinal products in the EUIn recent years, we have witnessed a constantly growing interest from all...
Read More >
Produced in partnership with Vincenzo Salvatore of BonelliErede 25th Jul
Precedents

Confidentiality letter—one-way—pro-discloser

Confidentiality letter—one-way—pro-discloser[insert address of sender]Our ref: [insert reference]Your ref: [insert reference][insert address of...
Read More >
25th Jul
tag iconIn-house
Precedents

Confidentiality letter—one-way—pro-recipient

Confidentiality letter—one-way—pro-recipient[insert address of sender]Our ref: [insert reference]Your ref: [insert reference][insert address of...
Read More >
25th Jul
Practice notes

Clinical trials

Clinical trialsThe purpose of clinical trialsA clinical trial is an investigation conducted in human subjects which aims to discover or verify the...
Read More >
25th Jul
Precedents

Confidentiality agreement—one-way—pro-discloser

Confidentiality agreement—one-way—pro-discloserThis Agreement is made on [date]Parties1[Insert name of party][ of [insert details] OR a company...
Read More >
Produced in partnership with Gateley 25th Jul
tag iconIn-house
Practice notes

The EU Clinical Trials Regulation

The EU Clinical Trials RegulationNew EU regulation on clinical trialsThis Practice Note covers the new Regulation (EU) 536/2014 on clinical trials,...
Read More >
Produced in partnership with Eveline Van Keymeulen of Allen & Overy and Marco de Morpurgo 25th Jul
Practice notes

Introduction to technology transfer agreements in the Life Sciences industry

Introduction to technology transfer agreements in the Life Sciences industryWhat is a technology transfer agreement?The term ‘technology transfer...
Read More >
Produced in partnership with Thomas Bjorn 25th Jul
Q&As

Is a pharmaceutical company sponsor of a clinical trial obliged to provide access to the trial medicine free of charge once the trial is finished?

Is a pharmaceutical company sponsor of a clinical trial obliged to provide access to the trial medicine free of charge once the trial is...
Read More >
25th Jul
Precedents

EU Clinical Trials Regulation—training materials

EU Clinical Trials Regulation—training materialsThese training materials consist of template PowerPoint slides that can be used as the basis of one or...
Read More >
28th Jun
Q&As

Which laws and regulations govern health care apps (mHealth)?

Which laws and regulations govern health care apps (mHealth)?Regulation as a medical deviceAn app may, depending on the specific characteristics and...
Read More >
6th Jun
Q&As

What are the implications for an insured who participates in clinical trials but fails to notify his insurers of any existing health conditions or potential changes to his health which he discovers as a result?

What are the implications for an insured who participates in clinical trials but fails to notify his insurers of any existing health conditions or...
Read More >
Produced in partnership with Julia Dias QC of 7KBW 6th Jun

Popular documents

Methods of statutory interpretation used to resolve ambiguities in legislation

Methods of statutory interpretation used to resolve ambiguities in legislation

Methods of statutory interpretation used to resolve ambiguities in legislationIP COMPLETION DAY: 11pm (GMT) on 31 December 2020 marks the end of the Brexit transition/implementation period entered into following the UK’s withdrawal from the EU. At this point in time (referred to in UK law as ‘IP

PRA Rulebook—introduction for the insurance and reinsurance sector

PRA Rulebook—introduction for the insurance and reinsurance sector

PRA Rulebook—introduction for the insurance and reinsurance sectorOn 29 August 2015, the Prudential Regulation Authority (PRA) published the PRA Rulebook (Rulebook). The transition from the Handbook to the Rulebook was intended to benefit PRA-authorised firms, to access clearer and more concise

Contractual damages—non-pecuniary losses

Contractual damages—non-pecuniary losses

Contractual damages—non-pecuniary lossesThis Practice Note considers the different categories of contractual damages that may be available for non-financial loss (non-pecuniary loss), ie punitive damages, damages for loss of enjoyment and loss of amenity, restitutionary damages and negotiating

Stay of proceedings—when can you apply to stay a claim?

Stay of proceedings—when can you apply to stay a claim?

Stay of proceedings—when can you apply to stay a claim?This Practice Note considers the question of when court proceedings can be stayed. It identifies scenarios in which a party may apply for a stay of proceedings, including to allow for: a jurisdictional challenge; arbitration; an attempt to